返回 Agendas
Session 11: FDA and Industry Town Hall
Session Chair(s)
Lisa LaVange, PHD
Professor Emerita
University of North Carolina at Chapel Hill, United States
Walter Offen, PHD
Global Head of Statistical Innovation & Safety Statistics
AbbVie Inc, United States
This session will be an open-microphone and broad Q&A session. Panelists will address questions posed by attendees in one of several manners: Via e-mail before or during the meeting, writing questions on 3x5 cards available at the registration desk, or by asking them live at the session. Topics may focus on the sessions held at this meeting, but can also branch out into other areas of regulatory statistics.
Speaker(s)
Panelists
Walter Offen, PHD
AbbVie Inc, United States
Global Head of Statistical Innovation & Safety Statistics
Jerald Schindler, DrPH
Strategic Statistics, United States
Chief Executive Officer
European Subgroup Guidance
Armin Koch, DRSC
Hannover Medical School, Germany
Head, Institute of Biometry
Christine Fletcher, MSC
GlaxoSmithKline, United Kingdom
VP/Head, Speciality and Primary Care Statistics
Nevine Zariffa
Astrazeneca Pharmaceuticals, United States
Vice President and Head Biometrics & Information Sciences
Rajeshwari Sridhara, PHD
FDA, United States
Senior Biostatistician Consultant, Oncology Center of Excellence, FDA
John Scott, PHD, MA
FDA, United States
Division Director, Office of Biostatistics, CBER
Steve Wilson, PHD
FDA, United States
Senior Staff Fellow, OB, OTS, CDER